Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MIR202 host gene (MIR202HG) is a **long non-coding RNA (lncRNA)** located on chromosome 17, hosting the microRNA **miR-202** within its transcript[1][2]. As a non-protein coding gene, **MIR202HG does not encode a protein**, but is believed to play regulatory roles at the RNA level, potentially modulating the expression of other genes via its host miRNA[1]. Altered expression of MIR202HG has been observed in various cancers, where it may influence cell proliferation, apoptosis, tumor growth, and metastasis, although the specific mechanisms remain incompletely characterized[1]. MIR202HG is primarily classified as a **non-coding regulatory RNA** rather than a classical therapeutic target such as a receptor, enzyme, or transporter, and currently there are no known drugs that directly target MIR202HG[1][2]. Further research is needed to clarify its functions and clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MIR202 host gene (non-protein coding) (MIR202HG).